- 同
- hereditary coproporphyria
WordNet
- the 8th letter of the Roman alphabet (同)h
PrepTutorEJDIC
- hydrogenの化学記号
- 鉛筆の硬度 / 《俗》heroin
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/06/15 15:23:57」(JST)
[Wiki ja表示]
HCP, hcp
HCP[編集]
- HCPチャート (Hierarchical ComPact) - プログラム設計図法
- ハートキャッチプリキュア! (HeartCatch PreCure!) - 2010年のテレビアニメ
- 遺伝性コプロポルフィリン症 (hereditary coproporphyria)
hcp[編集]
- 六方最密充填構造 (hexagonal close‐packed) - 結晶構造の分類
|
このページは曖昧さ回避のためのページです。一つの言葉や名前が二つ以上の意味や物に用いられている場合の水先案内のために、異なる用法を一覧にしてあります。お探しの用語に一番近い記事を選んで下さい。このページへリンクしているページを見つけたら、リンクを適切な項目に張り替えて下さい。 |
[Wiki en表示]
- H. Cegielski - Poznań S.A., a Polish manufacturing company from Poznań
- Habitat Conservation Plan
- CRC Handbook of Chemistry and Physics, published by CRC Press
- High Card Points, a contract bridge term
- Hardcore porn, explicit pornography with strong sexual content
- Health Care Property Investors, Inc. is a REIT focused on hospital and medical facilities investments
- Health care provider
- Hereditary coproporphyria, a deficiency disease
- Hexagonal close-packed is an arrangement of spheres into the closest packed arrangement
- High Court Petition
- Hitachi Content Platform
- (Dynamic) Host Configuration Protocol, a protocol used by networked computers
- Hot copy, a Linux command line utility (hcp)
- Hypnotize Camp Posse is a rap music record label founded by Three 6 Mafia
- Methylidynephosphane, a molecule with the chemical formula HCP
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes.
- Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK.Author information 1 Oregon Health & Science University , Portland, Oregon.AbstractAbstract Objectives: This study aimed to examine healthcare provider (HCP) recommendations and patient preferences for the insulin pen versus vial-and-syringe in patients with type 2 diabetes mellitus (T2DM) and to assess clinical end points and safety outcomes. Subjects and Methods: Using a randomized, open-label, crossover design, in total, 405 insulin-naive adults with T2DM from 60 centers received basal insulin glargine in one of two device treatment sequences (2 weeks of pen followed by 2 weeks of vial-and-syringe, or vice versa). The primary end point, patient device preference, was evaluated at Week 4 (end of the crossover period) using the Insulin Injection Preference Questionnaire. Patient preference and HCP recommendation were assessed with one global item and three subscale items (blood glucose control, reluctance to use insulin, and long-term insulin use) using a 5-point scale ranging from 1=not preferred or not recommended to 5=preferred or recommended. Patients were then re-randomized to either pen or vial-and-syringe for further observation (6, 10, and 30 weeks) to evaluate clinical end points (glycosylated hemoglobin [A1C] and fasting blood glucose levels) and safety outcomes (hypoglycemia and adverse events). Results: Patients reported a significant preference for pens over vial-and-syringe, and HCPs strongly recommended pens over vial-and-syringe (both P<0.001). Consistent response patterns were observed by HCPs and patients for the three subscale items. Fasting blood glucose, A1C levels, and the incidence of hypoglycemia were comparable in the two groups. Conclusions: Patients preferred pens over vial-and-syringe, with the pen device also recommended by HCPs, when initiating basal insulin treatment in insulin-naive patients with T2DM.
- Diabetes technology & therapeutics.Diabetes Technol Ther.2014 Feb;16(2):76-83. doi: 10.1089/dia.2013.0172. Epub 2013 Nov 23.
- Abstract Objectives: This study aimed to examine healthcare provider (HCP) recommendations and patient preferences for the insulin pen versus vial-and-syringe in patients with type 2 diabetes mellitus (T2DM) and to assess clinical end points and safety outcomes. Subjects and Methods: Using a randomi
- PMID 24266497
- Predictors of health care professionals' attitudes towards involvement in safety-relevant behaviours.
- Davis R, Briggs M, Arora S, Moss R, Schwappach D.Author information Clinical Safety Research Unit, Department of Bio-Surgery and Surgical Technology, Imperial College London, London, UK.AbstractBACKGROUND: Patients can make valuable contributions towards promoting the safety of their health care. Health care professionals (HCPs) could play an important role in encouraging patient involvement in safety-relevant behaviours. However, to date factors that determine HCPs' attitudes towards patient participation in this area remain largely unexplored.
- Journal of evaluation in clinical practice.J Eval Clin Pract.2014 Feb;20(1):12-9. doi: 10.1111/jep.12073. Epub 2013 Aug 13.
- BACKGROUND: Patients can make valuable contributions towards promoting the safety of their health care. Health care professionals (HCPs) could play an important role in encouraging patient involvement in safety-relevant behaviours. However, to date factors that determine HCPs' attitudes towards pati
- PMID 23937633
- Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011.
- Lu PJ1, Graitcer SB2, O'Halloran A2, Liang JL3.Author information 1Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States. Electronic address: lhp8@cdc.gov.2Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.3Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, United States.AbstractBACKGROUND: Health-care personnel (HCP) are at risk for exposure to and possible transmission of vaccine-preventable diseases. Receiving recommended vaccines is an essential prevention practice for HCP to protect themselves and their patients. The tetanus, diphtheria and acellular pertussis vaccine (Tdap) was recommended by the Advisory Committee on Immunization Practices (ACIP) for HCP in 2006 for protection against pertussis. We assessed the recent compliance of U.S. HCP in receiving Tdap vaccination.
- Vaccine.Vaccine.2014 Jan 23;32(5):572-8. doi: 10.1016/j.vaccine.2013.11.077. Epub 2013 Dec 3.
- BACKGROUND: Health-care personnel (HCP) are at risk for exposure to and possible transmission of vaccine-preventable diseases. Receiving recommended vaccines is an essential prevention practice for HCP to protect themselves and their patients. The tetanus, diphtheria and acellular pertussis vaccine
- PMID 24308960
Japanese Journal
- Recent Progress in Alloy Designs for High-Entropy Crystalline and Glassy Alloys (特集 金属ガラス・ナノ結晶材料の構造制御と応用に関する新たな展開)
- (61)Ni synchrotron radiation-based Mössbauer spectroscopy of nickel-based nanoparticles with hexagonal structure.
- Aging Effect of Mg-Sc Alloy with α+β Two-Phase Microstructure
Related Links
- HCPチャート. 出典: フリー百科事典『ウィキペディア(Wikipedia)』. 移動: 案内、 検索. HCPチャート(Hierarchical ComPact description chart)とは、日本電信電話公社(現 NTT)の横須賀電気通信研究所で開発されたプログラム設計図法である。
Related Pictures
![hcp view. The differentcolours show the A](https://1mg.info/0/9/m/1161.jpg)
![hcp hcp inc invests in real estate serving](https://1mg.info/0/9/m/1162.jpg)
![AULA DE TECNOLOGÍAS: Redes cristalinas de](https://1mg.info/0/9/m/1163.jpg)
![HCP and CCP are the simplest and most](https://1mg.info/0/9/m/1164.jpg)
![Packing density in the hcp structure](https://1mg.info/0/9/m/1165.jpg)
![Description HCP crystal structure.svg](https://1mg.info/0/9/m/1166.jpg)
![In a common solid there will be many](https://1mg.info/0/9/m/1167.jpg)
★リンクテーブル★
[★]
- 英
- hepatic coproporphyria HCP
- 同
- 遺伝性コプロポルフィリン症 hereditary coproporphyria
- 関
- 肝性ポルフィリン症、急性ポルフィリン症
[★]